Literature DB >> 18720959

Temperature-sensitive nonionic vesicles prepared from Span 80 (sorbitan monooleate).

Keiichi Kato1, Peter Walde, Norio Koine, Sosaku Ichikawa, Takashi Ishikawa, Ryo Nagahama, Takehiko Ishihara, Tetsuya Tsujii, Masachika Shudou, Yousuke Omokawa, Takashi Kuroiwa.   

Abstract

Different types of nonionic vesicles were prepared from commercial Span 80 (also called sorbitan monooleate), as an inexpensive, biocompatible alternative to conventional phospholipid-based vesicles (liposomes). The vesicles were characterized by different techniques and comparison was made with vesicles formed from POPC (1-palmitoyl-2-oleoyl- sn-glycero-3-phosphocholine) or DOPC (1,2-dioleoyl- sn-glycero-3-phosphocholine). Dynamic light scattering measurements, electron microscopy analyses, and two types of fusion assays indicate that Span 80 vesicles are stable for at least 7 days at 4 or 25 degrees C, while storage at 42 degrees C causes irreversible vesicle fusion. This indicates that Span 80 vesicles are thermoresponsive with vesicle fusion occurring at elevated temperature. This property may be related to headgroup dehydration and is certainly not directly linked to the phase transition temperature (Tm) of the vesicles, since the Tm is below -30 degrees C, as determined by differential scanning calorimetry (DSC). The measured Tm value for Span 80 vesicles is lower than in the case of DOPC or POPC, correlating with a higher fluidity of Span 80 vesicles as compared to POPC or DOPC vesicles, as determined with DPH (1,6-diphenyl-1,3,5-hexatriene) as fluorescent membrane probe. High fluidity correlates with increased leakage of entrapped water-soluble dye molecules. Addition of cholesterol and soybean phosphatidylcholine lowers the extent of leakage, allowing a tuning of the bilayer permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720959     DOI: 10.1021/la801581f

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  7 in total

1.  pH-responsive aggregation states of chiral polymerizable amphiphiles from L-tyrosine and L-phenyl alanine in water.

Authors:  Jasmeet Singh; Radha Ranganathan; S Angayarkanny; Geetha Baskar; A B Mandal
Journal:  Langmuir       Date:  2013-04-29       Impact factor: 3.882

2.  Enhanced cytotoxicity for colon 26 cells using doxorubicin-loaded sorbitan monooleate (Span 80) vesicles.

Authors:  Keita Hayashi; Tsuyoshi Tatsui; Toshinori Shimanouchi; Hiroshi Umakoshi
Journal:  Int J Biol Sci       Date:  2013-01-17       Impact factor: 6.580

3.  Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.

Authors:  Hiroshi Nakata; Tatsuhiko Miyazaki; Tomoyuki Iwasaki; Atsushi Nakamura; Teruki Kidani; Kenshi Sakayama; Junya Masumoto; Hiromasa Miura
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

4.  Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting.

Authors:  Rokaya O Amara; Alyaa A Ramadan; Riham M El-Moslemany; Maha M Eissa; Mervat Z El-Azzouni; Labiba K El-Khordagui
Journal:  Int J Nanomedicine       Date:  2018-08-06

5.  Effect of Vitamin E and a Long-Chain Alcohol n-Octanol on the Carbohydrate-Based Nonionic Amphiphile Sucrose Monolaurate-Formulation of Newly Developed Niosomes and Application in Cell Imaging.

Authors:  Arpita Roy; Arghajit Pyne; Pallabi Pal; Santanu Dhara; Nilmoni Sarkar
Journal:  ACS Omega       Date:  2017-11-07

6.  Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin Eucheuma serra Agglutinin Isolated from a Marine Red Alga.

Authors:  Keita Hayashi; Peter Walde; Tatsuhiko Miyazaki; Kenshi Sakayama; Atsushi Nakamura; Kenji Kameda; Seizo Masuda; Hiroshi Umakoshi; Keiichi Kato
Journal:  J Drug Deliv       Date:  2012-12-27

7.  Niosomes, an alternative for liposomal delivery.

Authors:  Rianne Bartelds; Mohammad Hadi Nematollahi; Tjeerd Pols; Marc C A Stuart; Abbas Pardakhty; Gholamreza Asadikaram; Bert Poolman
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.